Abstract:The circadian clocks help maintain homeostasis by regulating various metabolic and biological processes within organisms and cells. Disturbances in the body's circadian rhythm have been associated with the development and progression of cancer. The expression patterns of clock genes in cancer tissues differ from those in normal tissues. Disruption of circadian rhythms accelerates cancer cell proliferation and promotes the occurrence and progression of cancer by affecting cell cycle, regulating apoptosis, and other events. Given the crucial role of circadian rhythms in cancer progression, chronotherapy, tailored to the physiological rhythms of cancer tissues, has been widely studied in recent years. This review explores the composition and function of molecular clocks in cancer tissues, summarizes the current state of cancer chronotherapy, and highlights biomarkers from cutting-edge research that may guide personalized chronotherapy, aiming to provide new insights for the development of highly effective and precise personalized cancer chronotherapy.